当前位置：
X-MOL 学术
›
JAMA Neurol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 Lockdown.
JAMA Neurology ( IF 20.4 ) Pub Date : 2023-02-13 , DOI: 10.1001/jamaneurol.2022.5346 Adam E. Handel 1, 2 , Jacqueline Palace 1 , Elizabeth Bateman 3 , Patrick Waters 1, 2 , Sarosh R. Irani 1, 2
JAMA Neurology ( IF 20.4 ) Pub Date : 2023-02-13 , DOI: 10.1001/jamaneurol.2022.5346 Adam E. Handel 1, 2 , Jacqueline Palace 1 , Elizabeth Bateman 3 , Patrick Waters 1, 2 , Sarosh R. Irani 1, 2
Affiliation
This case-control study investigates the positivity rates of the most prevalent neuroglial surface antibodies during the COVID-19 pandemic.
中文翻译：
COVID-19 封锁期间富含亮氨酸胶质瘤灭活 1 血清阳性率的变化。
这项病例对照研究调查了 COVID-19 大流行期间最普遍的神经胶质细胞表面抗体的阳性率。
更新日期：2023-02-13
中文翻译：
COVID-19 封锁期间富含亮氨酸胶质瘤灭活 1 血清阳性率的变化。
这项病例对照研究调查了 COVID-19 大流行期间最普遍的神经胶质细胞表面抗体的阳性率。
京公网安备 11010802027423号